Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion

Status:
Completed

Trial end date:
2016-05-09

Target enrollment:

Participant gender:

The purpose of this study is to observe the anatomical and functional outcomes of ocriplasmin (JETREA™®) over a 6-month period.

Phase 4

Alcon Research